All News NEURONES

Equities

Market Closed - Euronext Paris Other stock markets 11:35:14 2024-05-03 am EDT			5-day change	1st Jan Change
45.65 ^EUR	+1.44%		+2.13%	+4.34%

Mar. 07	Neurones: 11% growth in annual net income	CF
Mar. 06	Neurones S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

NEURONES : Letter to shareholders - may 2024	May. 03	PU
NEURONES : Letter to shareholders - april 2024	Apr. 25	PU
Neurones: 11% growth in annual net income	Mar. 07	CF
NEURONES: Net profit (group share) up 11.5% in 2023	Mar. 06	GL
NEURONES: Net profit (group share) up 11.5% in 2023	Mar. 06	AQ
Neurones S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 06	CI
Neurones: 11% growth in annual sales	Feb. 08	CF
NEURONES: 11.1% organic growth in 2023	Feb. 07	GL
Neurones: sales growth of 11.4% in Q3	Nov. 09	CF
NEURONES: Organic growth up 12.3% over the first nine months of the year	Nov. 08	GL
NEURONES: Organic growth up 12.3% over the first nine months of the year	Nov. 08	AQ
Neurones S.A. Provides Earnings Guidance for the Year 2023	Nov. 08	CI
Neurones S.A. Announces Revenue Results for the Third Quarter and Nine Months of 2023	Nov. 08	CI
NEURONES : Letter to shareholders - october 2023	23-10-17	PU
Neurones: net income up 16.3% in 1st half	23-09-06	CF
NEURONES : 8.1% net profit in 1st half 2023	23-09-06	PU
NEURONES: 8.1% net profit in 1st half 2023	23-09-06	GL
NEURONES: 8.1% net profit in 1st half 2023	23-09-06	AQ
Neurones S.A. Provides Earnings Guidance for the Full Year 2023	23-09-06	CI
Neurones S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-06	CI

No results for this search